Answers are grounded in this paper and cite their sources.
Supplementary Figure S11. Proportions of patients with AVPCmDNA and genomic alterations in p53, RB1, and PTEN in each group based on WES of metastatic tumor biopsies from patients in the Satisfactory group (n=37, in red) and in the Unsatisfactory group (n=22, in blue).
No takes yet. Share an insight, caveat, or question.
Aparicio et al. (2024) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: